<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03127553</url>
  </required_header>
  <id_info>
    <org_study_id>ProAliFun_6.7_CE4373</org_study_id>
    <nct_id>NCT03127553</nct_id>
  </id_info>
  <brief_title>ProAliFun_6.7_Health Effects of a Low-Salt Bread on Hypertensive Subjects (ProAliFun67)</brief_title>
  <official_title>Technological and Clinical Innovative Protocols for the Production of Functional Foods - 6.7 (ProAliFun67)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Consorziale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ospedali Riuniti di Foggia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Consorziale</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to evaluate the health properties of a dietary
      intervention carried on with an innovative low-salt bread.

      The hypothesis is that the introduction of a low-sodium bread as part of a low-salt diet may
      improve the compliance to the own regime and that the vascular function, the inflammatory and
      oxidative state, the composition of the intestinal microbiota and that neurocognitive and
      neurodegenerative processes can improve in hypertensive patients fed a low-salt diet with
      low-salt bread.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical trial is a multi-center, randomized, controlled, open label, pilot study,
      lasting 6 months.

      A target number of seventy individuals with hypertension meeting inclusion and exclusion
      criteria, assessed at enrollment, and which have signed the informed consent, will be
      recruited.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sodium intake</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction of sodium intake in diet with the introduction of the innovative formulation of low-salt bread</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction of blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial stress</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement of flow-mediated dilation FMD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut microbiota</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of gut microbiota modulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antioxidant status</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the antioxidant/oxidant ratio of blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation</measure>
    <time_frame>6 months</time_frame>
    <description>State of sub-clinical inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction of insulin sensitivity</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>A - control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Free diet with standard bread</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B - low-salt diet with normal bread</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-sodium diet with standard bread</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C - low-salt diet with low-salt bread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low-sodium diet with low-sodium bread</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low-sodium diet with standard bread</intervention_name>
    <description>low-sodium diet (2300 mg Na/die) with use of standard bread (750 mg Na/100g) for 6 months</description>
    <arm_group_label>B - low-salt diet with normal bread</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low-sodium diet with low-sodium bread</intervention_name>
    <description>low-sodium diet (2300 mg Na/die) with use of low-salt bread (280 mg Na/100g) for 6 months</description>
    <arm_group_label>C - low-salt diet with low-salt bread</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  arterial hypertension stage I-II

          -  stable control of blood pressure

          -  eGFR &gt; 60

          -  informed consent signed

        Exclusion Criteria:

          -  uncontrolled hypertension

          -  therapy with diuretics

          -  need for therapy with more than three antihypertensive drugs

          -  proteinuria greater than 1 g/day

          -  celiac disease

          -  systemic inflammatory diseases

          -  suspicion or clinical diagnosis of malignancy

          -  chronic liver disease

          -  treatment with corticosteroids or immunosuppressive drugs

          -  previous acute cardiovascular diseases (myocardial infarction, stroke)

          -  psychiatric conditions reducing the compliance to treatment protocols
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loreto Gesualdo, MD Full Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of the Nephrology, Dialysis and Transplantation Unit &quot;Aldo Moro&quot; University of Bari Azienda Ospedaliero-Universitaria Consorziale &quot;Policlinico&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AUO Policlinico Consorziale</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <zip>70125</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>salt intake</keyword>
  <keyword>functional food</keyword>
  <keyword>low-salt bread</keyword>
  <keyword>blood pressure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

